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Systems biology analysis of drivers 
underlying hallmarks of cancer cell 
metabolism
Daniel C. Zielinski1, Neema Jamshidi1,2, Austin J. Corbett1, Aarash Bordbar1,†, Alex Thomas3,4,5 
& Bernhard O. Palsson1,5
Malignant transformation is often accompanied by significant metabolic changes. To identify drivers 
underlying these changes, we calculated metabolic flux states for the NCI60 cell line collection and 
correlated the variance between metabolic states of these lines with their other properties. The 
analysis revealed a remarkably consistent structure underlying high flux metabolism. The three 
primary uptake pathways, glucose, glutamine and serine, are each characterized by three features: 
(1) metabolite uptake sufficient for the stoichiometric requirement to sustain observed growth, (2) 
overflow metabolism, which scales with excess nutrient uptake over the basal growth requirement, 
and (3) redox production, which also scales with nutrient uptake but greatly exceeds the requirement 
for growth. We discovered that resistance to chemotherapeutic drugs in these lines broadly correlates 
with the amount of glucose uptake. These results support an interpretation of the Warburg effect and 
glutamine addiction as features of a growth state that provides resistance to metabolic stress through 
excess redox and energy production. Furthermore, overflow metabolism observed may indicate 
that mitochondrial catabolic capacity is a key constraint setting an upper limit on the rate of cofactor 
production possible. These results provide a greater context within which the metabolic alterations in 
cancer can be understood.
Over the past decade there has been a revival of metabolic research in oncology1. In particular, two defining char-
acteristics of cancer metabolism have received much attention: (1) an increased glucose uptake rate accompanied 
by secretion of lactate even in the presence of oxygen, known as the Warburg effect2, and (2) a high glutamine 
uptake rate essential for growth, known as glutamine addiction3–7. Despite the central role these traits play in the 
discussion of cancer metabolism, the drivers underlying these traits are still debated8. It is important to under-
stand these drivers as cancer metabolism is likely to become a focus of chemotherapeutics development1,3,9.
The NCI60 cell line collection consists of 60 cancer cell lines that have been extensively used as a model to 
study characteristics of cancer cells over the past quarter of a century10–14. Notably, the metabolite uptake and 
secretion profiles for these lines were recently published11. When coupled to growth15 and cell size data14, these 
data provide the opportunity to study cancer metabolic functional states at an unprecedented scale by utilizing 
flux balance analysis (FBA)16. Fundamentally structured in the context of metabolic mass, energy and redox bal-
ance, FBA has been utilized successfully over the past decade as a method of data integration17 as well as a number 
of other applications18, including cancer metabolism19–21. Using FBA, we integrated available metabolic data to 
calculate metabolic flux states for the NCI60 panel. We then leveraged the differences in metabolic flux states 
across the NCI60 panel to identify drivers underlying two dominant features of cancer metabolism: the Warburg 
effect and glutamine addiction.
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Results
Data-driven calculation of metabolic fluxes for the NCI60 cell line panel. First, we calculated met-
abolic reaction fluxes for each cell line in the NCI60 collection using FBA on a core cancer metabolic model 
constrained by measured cell line-specific uptake and secretion rates for 23 metabolites11, representing > 99% 
of carbon exchange, as well as growth rates and cell sizes (Methods). This core model was derived from the 
human metabolic network reconstruction Recon 222 and consisted of high confidence (i.e. highly expressed and/
or essential) growth and energy pathways (Fig. 1a, see Methods). Genome-scale cell line-specific models were 
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Figure 1. Data-driven characterization of the high flux backbone of the cancer metabolic network. (a) 
The workflow utilized in this study for the constraint-based calculation of metabolic flux states for the NCI60 
panel using available data and a core metabolic model extracted from the global human metabolic network 
reconstruction Recon 222. (b) Comparison of flux balance analysis results to a previously published 13C-labeled 
glucose tracing experiment on the A549 line. The computed flux solutions were corrected for a substantial 
difference in measured lactate secretion prior to comparison (Supplementary Data, Supplementary Methods). 
(c) Comparison of flux balance analysis results to a previously published 13C-labeled glucose tracing experiment 
on the MCF-7 line. The computed flux distributions were corrected for a difference in the active form of malic 
enzyme, which is forced by glutamine uptake to be the mitochondrial isozyme, consistent with other studies36 
(Supplementary Data, Supplementary Methods). Point labeled ‘A’: Citrate shuttling to lipid synthesis is not 
observed in the data but is forced to be active in the model by lipid synthesis requirements. (d) Comparison 
of FBA-calculated and measured oxygen uptake rate data for a subset of the NCI60 lines. (e) Principle 
component analysis (PCA) of the flux balance analysis (FBA) calculated flux distribution of the NCI60 cell 
lines. (f) Correlation between the first principle component and the growth rates. (g) Correlation between the 
second principle component and glucose uptakes. Abbreviations: PPP- pentose phosphate pathway, TCA – 
tricarboxylic acid, ETC – electron transport chain, AA – amino acid, NEAA – non-essential amino acid, (d) 
NTP – (deoxy) nucleotide triphosphate.
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also constructed and evaluated (Supplementary Fig. 2), but inconsistencies between expression calls and known 
pathway function discouraged us from proceeding with their use (Supplementary Fig. 2d). Using reported kary-
otypes23, cell sizes14, and typical mammalian cell compositions24,25, we estimated cell-specific biomass composi-
tions for each cell line26 (see Methods, Supplementary Data). These biomass compositions differ primarily in their 
fractional DNA content, as the karyotypes were the only reliable information on cell-specific biomass composi-
tion, while the protein fraction was assumed constant across cell lines. Cell line-specific protein fractions would 
likely increase the resolution of predicted cell line-specific flux states.
Flux balance analysis was run on each individually-constrained cell line with an NADPH maximization objec-
tive, as the other typical candidates for optimization objectives, which are ATP production and growth rate, were 
set based on measured data15,25. This objective also gave the best agreement with 13C tracing data (Supplementary 
Text and Data), and thus appeared to give the best estimate of fluxes for further analysis. ATP maintenance 
requirements were set based on data for a mouse LS line25, as a cancer cell line-specific value was not available. 
Furthermore, the glycolysis/pentose phosphate pathway ratio and the pyruvate dehydrogenase/pyruvate carbox-
ylase ratios were constrained to 10% of the major pathway (glycolysis and PDH, respectively) based on previous 
13C studies27,28 due to uncertainty and large model variation around these flux splits, and the glutamate and isoc-
itrate dehydrogenases were assumed equally NAD versus NADP dependent. The uncertainty in flux splits is in 
large part due to the unknown non-biosynthetic NADPH demand due to oxidative stress, as well as unknown 
CO2 production, which together would provide additional knowledge on the activity of these pathways. As a sen-
sitivity analysis, we varied these ratios between 1% and 20% of the major pathway and found that these ratios do 
not significantly impact the overall flux solution, with Pearson correlations for the same cell line greater than 0.99 
being observed (Supplementary Data). This small impact appears to be due to the fact that the minor pathways 
control relatively small fractions of the cellular flux, and there may be alternate pathways that compensate for 
altered constraints on these ratios.
The flux states computed with the core model showed an excellent correlation with 13C data available for the 
A549 and MCF-7 lines27,28 (Pearson R2 > 0.95) (Fig. 1b,c) as well as measured oxygen uptake rates for a subset 
of lines with available data (average error of 17%)29 (Fig. 1d). As the calculation was partially fit to these flux 
states due to constraining certain flux splits (Methods), this agreement can be interpreted as verification rather 
than completely independent validation. However, this agreement is still important to obtain flux states that are 
more likely to be accurate for the purpose of downstream analysis. Notably, the oxygen data was not used as a 
constraint, and so agreement between predictions and data is especially encouraging. Furthermore, no cell line 
reached the upper limit we set on oxygen uptake of 2 mmol/gDW/hr, based on the observed range in mammalian 
cell lines29, indicating that oxygen uptake is not a governing constraint on these flux states given the objective 
function we used.
Principle component analysis (PCA) revealed that the metabolic states of the NCI60 lines are structurally sim-
ple (Fig. 1e, Supplementary Fig. 4), with large part of the variance explained by growth rate (Fig. 1f) and glucose 
uptake differences (Fig. 1g) (Supplementary Data). Among measured fluxes, glutamine uptake also makes a major 
contribution to the second principal component, as well as the dependent unmeasured exchange reactions for 
oxygen and CO2, suggesting that the second component can be interpreted as a total substrate intake component. 
Although there is no clear separation between distinct metabolic states apparent, examination of the states by 
tissue type shows some trends. For example, the leukemia-derived lines in the NCI60 tend to be characteristically 
fast growing with high substrate uptakes, while the colon-derived lines tend to be characteristically fast growing 
with low substrate uptakes.
Comparison of amino acid uptakes to biomass precursor demands. Consistent with the dominance 
of the metabolic state by growth rate, we find that uptake of many amino acids are determined largely by growth 
requirements (Fig. 2a). Growth requirements, or demands on biomass precursors, are calculated by multiplying 
the coefficient for the metabolite in the biomass reaction by the growth rate. In particular, we found that essential 
amino acids, as well as tyrosine that can be derived from the essential amino acid phenylalanine, are taken up 
at levels only slightly greater than is required to meet protein synthesis demands. Additionally, uptake of each 
essential amino acid was found to be correlated with their biosynthetic demand across cell lines, consistent with 
previous findings14.
We identified a similar dominance by growth demands among the related amino acids serine and glycine 
(Fig. 2b). We found that serine uptake is consistently greater than its biosynthetic requirements while glycine 
secretion rate is highly variable (Fig. 2c). However, the combined uptake and secretion of the two amino acids 
matches their combined biomass synthetic requirements (Fig. 2c), as has been observed14. Additionally, the cor-
relation of the uptake of the amino acid group as a whole with biosynthetic demand is higher than the correlation 
considering each amino acid separately. These results suggest that serine uptake acts as a reservoir to meet protein 
synthesis requirements for the two amino acids.
Looking then at the other major group of non-essential amino acids, which are linked through glutamate 
(Fig. 2d), we found the dominance of growth requirements to be less consistent. We found that, on average, aspar-
agine, arginine, and aspartate are taken up about the levels of their biosynthetic demand, but with a lower cor-
relation than in the case of the essential amino acids (Fig. 2e). However, glutamate, alanine, and proline were all 
consistently secreted, suggesting no direct connection between their uptake and growth requirement. Meanwhile, 
glutamine was taken up on average 32 times more than its biosynthetic requirement, an extremely high uptake 
rate demonstrative of the glutamine addiction phenotype (Fig. 2e).
Determining the driver underlying glutamine uptake in the NCI60 cell line panel. To deter-
mine whether the high glutamine uptake is tied to the biosynthetic requirement for nitrogen groups as a whole, 
we looked at the amine balance with and without glutamine uptake considered (Fig. 2f). It was found that the 
www.nature.com/scientificreports/
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Figure 2. Amino acid metabolism is determined by protein synthesis demands and coupled to overflow 
metabolism. (a) Quantile plot of essential amino acid uptake compared with protein synthesis demand. Each 
band in the quantile plot represents the bounds of a particular quantile. Ten quantiles are shown. Listed above 
each bar is the Spearman correlation R2 of the amino acid uptake with biosynthetic requirement across lines. (b) 
Overview of serine and glycine synthesis pathway. (c) Quantile plots of the uptakes of serine and glycine relative 
to their demand from protein synthesis. (d) Overview of the metabolism of glutamine and related biosynthetic 
precursors, highlighting the role of glutamine in amine donation as well as its primary catabolic route 
through glutaminase and glutamate dehydrogenase. (e) Quantile plots of uptakes of glutamine-related amino 
acids compared to their protein synthesis requirement. (f) Overall amine balance due to protein synthesis 
requirement. (g) Fraction of glutamine uptake metabolized through glutamate dehydrogenase, with an average 
of 70%. (h) Correlation between glutamate dehydrogenase and the mitochondrial malic enzyme demonstrates 
that glutamine is primarily converted to pyruvate through malic enzyme, producing mitochondrial NADPH. (i) 
Fraction of malic enzyme flux due to alpha-ketoglutarate produced from alanine transaminase tied to alanine 
overflow, highlighting an alternate glutamine catabolic route.
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cell lines are in a nitrogen deficient state without considering glutamine, with a median deficient of 42% of the 
demand. However, after considering glutamine uptake, nitrogen is in excess of biosynthetic demands by a median 
of 400% of the biosynthetic requirement for amino acids. This result suggests that glutamine uptake is necessary 
to fulfill the amine requirement for growth, but this requirement is not sufficient alone to explain the very high 
level of glutamine uptake in these cell lines. Other sinks for nitrogen such as nucleotide triphosphate synthesis 
were negligible. Thus, glutamine addiction is not sufficiently explained by the necessity to produce amino acid 
precursors for protein synthesis.
We then examined the metabolic fate of the excessive glutamine taken up by NCI60 lines. We found that 
glutamate dehydrogenase (GLUD) metabolizes an average 70% of glutamine taken up (Fig. 2g). However, 
α -ketoglutarate (α KG) produced from this reaction greatly exceeds the requirement for TCA metabolites and 
cannot be fully oxidized by the TCA cycle due to the structure of the pathway. To be fully catabolized, α KG 
produced from GLUD must exit the TCA cycle via malic enzyme (ME) to be converted into pyruvate for later 
oxidation. This pathway produces mitochondrial NADPH through GLUD and ME in a manner that scales with 
glutamine uptake. Simultaneously, an alternate pathway to glutamine catabolism through alanine transaminase 
exists that results in secretion of alanine, as is observed in these lines. These pathways can alternately be pow-
ered by glucose by producing oxaloacetate via pyruvate carboxylation, but this pathway is consistently meas-
ured as carrying relatively low flux12,13. We found that the primary route for glutamine catabolism is through 
this mitochondrial NADPH-producing malic enzyme pathway, as evidenced by correlations between gluta-
mate dehydrogenase and alanine transaminase with malic enzyme activity (Fig. 2g,i). This pathway is primarily 
glutamine-driven rather than glucose-driven, and thus supports the idea that primary role of the high glutamine 
uptake is to produce mitochondrial NADPH, rather than to produce amine equivalents for protein synthesis.
Calculating sources and sink of ATP production and drivers of the Warburg phenotype. Next, 
we sought to apply a similar analysis to glucose metabolism, which is typically considered to be the primary 
source of energy in the cancer metabolic phenotype. Calculating the balance of NTP production and consump-
tion (Fig. 3a,b), we determined that NTP production in the NCI60 lines has three main contributors: net glycol-
ysis (mean 44% of production), ATP synthase (mean 35%), and succinyl-CoA synthetase (mean 21%) (Fig. 3a). 
Net glycolysis is defined as glycolytic production (phosphoglycerate kinase and pyruvate kinase) minus glycolytic 
consumption (hexokinase and phosphofructokinase). This split of NTP production is consistent with previous 
estimates30, which place glycolysis at a slightly lower fraction of NTP production but agree that oxidative metab-
olism provides the majority of NTP. Looking at NTP demands, it is apparent that macromolecule and precursor 
synthesis only make up a minor part of the cellular NTP demand. A larger fraction is consumed by maintenance 
functions, such as the Na-K pump, or by undetermined functions that may consist of variable additional mainte-
nance costs or energy drains such as metabolic futile cycles.
We find that net glycolytic ATP production is set at a level that mostly (80%) satisfies the known growth 
and maintenance ATP requirements of the cell, with little apparent bias related to the cell line tissue of origin 
(Fig. 3c). However, due to the additional significant contribution of oxidative metabolism to ATP production, cell 
lines produce an excess of ATP, compared with known ATP demands25, that scales with glucose uptake (Fig. 2d). 
Additionally, there is an excess of redox production, in the form of both NADH and NADPH, over growth and 
energy demands that scales with glucose uptake as well (Fig. 3e). Thus, although glycolysis alone meets the growth 
requirements for ATP, the overall ATP and NADH energy requirement is exceeded due to the contributions from 
oxidative phosphorylation. To further quantify this excess, we calculated the minimum amount of glucose that 
could be taken up and still satisfy measured growth rate and known ATP demands (Supplementary Data). We 
calculated that the NCI60 cell lines on average could take up only 59% (standard deviation of 16%) of the actual 
measured glucose uptake and still satisfy known growth and energy requirements. Thus, it appears that there 
is additional metabolic flexibility due to high glucose uptake that appears to be driving cofactor production in 
excess of known demands.
Seeking to identify some relationship through which to understand this excess redox production, we corre-
lated the glucose uptake with a large set of available data on the NCI60 lines, including gene expression, drug 
response, metabolomics, and proteomics. Remarkably, we found that higher glucose uptake broadly correlated 
with resistance to chemotherapeutic compounds within the NCI Developmental Therapeutics Program database, 
which contains sensitivity data for 20500 compounds (Fig. 3f)10. This correlation was independent of the associa-
tion between drug sensitivity and cell growth rate. Notably, imatinib resistance is among the highest correlated to 
glucose uptake, and imatinib resistance has previously been shown to be associated with higher glucose uptake31.
Topological consistencies link the dominant uptake metabolites in cancer metabolism. Finally, 
looking at the question of what limits are placed upon the cancer metabolic phenotype, we make special note of a 
trend that was discovered among the three highest uptake metabolites: glucose, glutamine, and serine (Fig. 4a). We 
found that the uptake of each metabolite is coupled to secreted metabolites, which are lactate, glutamate, and glycine, 
respectively. First, glucose uptake is highly correlated with lactate secretion (Fig. 4b), a well-known feature of the 
Warburg effect. Second, glutamate secretion is significantly correlated with glutamine uptake, and consideration 
of alanine secretion as well improves this correlation (Fig. 4c). Finally, we found that glycine secretion increases as 
serine uptake increases above the cellular protein precursor requirement (Fig. 2d). Each of these secreted metab-
olites occur at branch points directly prior to a mitochondrial catabolic pathway. In the case of lactate (pyruvate) 
and glutamate, the pathway is the TCA cycle. In the case of glycine, the pathway is the glycine cleavage chain. The 
correlation of the excessive uptake of the high uptake metabolites with the secretion of coupled overflow metabolites 
may suggest that mitochondria are insufficiently able to catabolize the taken up metabolite. This could suggest that 
mitochondrial catabolic capacity is a governing constraint limiting the fast growing metabolic phenotype.
www.nature.com/scientificreports/
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Discussion
Taken together, the results of this structured analysis of disparate data types suggest a fundamental structure 
to cancer cell metabolism across multiple tissue types where biosynthetic demands are primary determinants 
of much of the metabolic phenotype. However, glucose and glutamine uptake rates scale above the biomass 
requirement resulting in an excess of redox and energy cofactor production beyond biosynthetic and energy 
requirements. These results suggest an interpretation of the Warburg effect and glutamine addiction as drivers 
of metabolic stress resistance. The role of these high uptake pathways on sustaining stress resistance has been 
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synthetase. It is observed that glycolysis provides on average ~60% of total ATP production, in line with 
previous measurements. (b) Fraction of ATP consumption by various cellular processes. (c) Fraction of cellular 
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demonstrated before in individual cases32. The idea that the metabolic shift from high yield to low yield metabo-
lism, such as in the Warburg effect, may be due to competition for redox cofactors has been suggested elsewhere 
in the literature33.
A number of other ideas have been put forth on the drivers underlying the Warburg effect and glutamine 
addiction. We used the abundance of available data on the NCI60 cell line panel with the rigorous metabolic 
network analysis framework to evaluate whether these alternate hypotheses may also be promising in explaining 
the origin of the Warburg effect and glutamine addiction. First, we looked at explanations put forth for ori-
gin of the Warburg effect. We examined the hypothesis that the shift to aerobic glycolysis occurs to supply the 
cell with biosynthetic precursors7, such as serine and UDP-glucose, required for synthesis of macromolecules. 
Metabolic models can simultaneously reconcile biosynthetic precursor and energy needs for growth34. We found 
that in no cell line was production of a glucose-derived biosynthetic precursor the limiting factor for growth 
(Supplementary Fig. 3d). In fact, synthesis of glucose-derived biosynthetic precursors quantitatively accounts for 
only a small fraction (< 10%) of glucose uptake in all cell lines (Supplementary Fig. 1a). One of several essential 
amino acids is the growth-limiting factor in all but two lines, in which ATP is limiting (Supplementary Fig. 3d). 
Furthermore, as we detailed above, serine is taken up sufficiently for both serine and glycine biosynthetic require-
ments. Taken together, the quantitative assessment of the need for metabolic resources afforded by the network 
models argues against the notion that biosynthetic precursor production is a driving factor underlying the 
Warburg effect. While variance in biomass composition, which we cannot easily account for, will affect these 
values, the calculated fraction of glucose going to biomass precursors seems too small for such variance to affect 
these conclusions.
Then, we examined a recently proposed hypothesis that the Warburg effect serves to reduce spatial constraints 
due to macromolecule crowding by shifting from high protein-requiring oxidative phosphorylation to primar-
ily glycolysis4,35. Much like the balance between redox production, growth, and mitochondrial catabolism pro-
posed in this work to explain the Warburg effect, this alternate hypothesis can be seen as driven by a ‘trade-off ’ 
relationship, where an apparently sub-optimal metabolic phenotype is adopted due to certain cellular limita-
tions. To examine this hypothesis, we analyzed published quantitative proteomics data for the NCI60 collec-
tion13. We found that metabolic proteins account for approximately 20% of the proteome, while 10% of proteins 
within metabolism are associated with the TCA cycle and oxidative phosphorylation (Supplementary Fig. 1b). 
Thus, within the NCI60 cell line collection, only approximately 2% of the proteome is associated with oxidative 
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Figure 4. Overflow metabolism in high flux pathways in the NCI60 cell lines. (a) High uptake metabolites 
are coupled to overflow metabolism at branch points occurring above mitochondrial catabolic pathways. 
(b) Comparison of lactate secretion with the glucose uptake rate. The strong correlation suggests a direct 
relationship between the metabolite exchanges. (c) Secretion of glutamate and alanine vs the glutamine uptake 
supporting a role of the former two metabolites in metabolic overflow. Although alanine secretion individually 
is not significantly correlated with glutamine uptake, considering glutamate and alanine simultaneously as 
a secreted pool improves the correlation with glutamine uptake over glutamate alone, suggesting glutamate 
and alanine may behave somewhat as a secreted pool. (d) Glycine secretion vs excess serine uptake, calculated 
as serine uptake minus serine and glycine protein synthesis demand. A significant correlation is observed, 
suggesting a role of glycine as an overflow metabolite when serine uptake exceeds the requirement for protein 
synthesis and ability to metabolize glycine through the glycine cleavage chain.
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phosphorylation, a small fraction that does not support the notion that the reduction of oxidative phosphoryl-
ation can significantly reduce macromolecule crowding. In a subsequent analysis, we hypothesized that if the 
Warburg effect is driven by a macromolecule crowding constraint, then a metric of macromolecular crowding 
should be inversely correlated with the degree of aerobic glycolysis within the line. We correlated the protein den-
sity within the NCI60 lines with two metrics of the Warburg effect based on calculated metabolic flux distribu-
tions. We did not find any positive association between the metrics and protein density however, further arguing 
against any functional connection between the degree of macromolecule crowding and the origin of the Warburg 
effect, at least at the whole cell level (Supplementary Fig. 1c).
We then examined existing hypothesis for drivers of glutamine addiction. First, we examined the idea that 
the role of glutamine’s high uptake is to provide the pool of TCA metabolites36. Glutamine has been shown to be 
the primary source of the TCA metabolite pool36. However, from a flux balance perspective, it appears that this 
cannot quantitatively explain the high level of glutamine uptake. Assuming a steady state, the TCA metabolite 
pool will gradually drain due to growth dilution. The rate of dilution is the current concentration of the metabo-
lite multiplied by the growth rate. Assuming a concentration on the high end of 1 mM, a growth rate of 0.02 hr−1, 
a cell mass of 0.3 ng, and a cell volume of 2 pL, which are approximate averages for the NCI60 lines, each TCA 
metabolite would need to be replenished at a rate of 0.13 uM/gDW/hr. However, glutamine uptake is an average of 
0.19 mM/gDW/hr for the NCI60 cell lines, three orders of magnitude higher. Thus, replenishing the TCA metab-
olite pool only demands a small fraction of glutamine uptake. Although glutamine enters the TCA cycle and 
provides TCA metabolites, this does not sufficient support that this is the primary reason for the high glutamine 
uptake, since the majority of glutamine cannot stay within the TCA cycle.
Second, it has been proposed that the cleavage of ammonia from glutamine and glutamate by glutaminase and 
glutamate dehydrogenase can serve as a pH buffer to mitigate the acid production due to lactate and CO2 production6. 
We contend that the production of NH4 can do very little to serve as a pH buffer for two reasons. First, neither of 
the enzymes glutaminase and glutamate dehydrogenase consume a proton directly as a reactant. Second, these 
reactions produce NH4 with the proton already bound, preventing the molecule from scavenging further protons 
produced from other processes. In line with this, we observe no correlation between glutamine uptake and any 
acid production metrics, including secreted protein, secreted lactate, and secreted CO2. However, this argument 
is flux-based and says nothing about a potential regulatory role that ammonium production may have.
One surprising result of this study was the broad correlation of glucose uptake with drug resistance in the 
NCI60 cell line panel. We note that this correlation was found between glucose uptake in per mass units as 
opposed to per cell units, which are the original units reported11. There is an important difference in the interpre-
tation of metabolic flux in these units. Because the cells are different masses, the fluxes per mass and per cell are 
not expected to correlate and any observed correlations with other variables such as drug resistance could have 
different interpretations. Two flux states in per cell units could potentially be the ‘same’ flux state in a qualitative 
sense, i.e. in terms of relative pathway usage, but simply scaled by the size of the cell; however, differences in flux 
in per mass units between cell types indicates a qualitative shift in pathway preferences within metabolism rather 
than a general scaling effect. Another study has shown a correlation of cell volume with cell mesenchymality, as 
measured by expression of the marker vimentin14. Also, cell volume is substantially correlated with glucose uptake 
in per cell units (Pearson R2 = 0.39). Thus, it may be conjectured that the mesenchymal nature of the cell could 
be the underlying origin of the observed drug resistance in high glucose uptake cell lines. However, while we did 
verify a correlation of vimentin with cell volume (Pearson R2 = 0.22), we found that mesenchymality as estimated 
by this marker does not correlate with drug resistance in these lines, with a median Pearson correlation coefficient 
r of − 0.04, indicating a non-significant relationship opposite of the hypothesized direction of correlation.
Investigating into the relationship between glucose uptake and drug resistance, we hypothesize that the excess 
redox and energy cofactor production by high glucose uptake lines provides a measure of resistance to metabolic 
stress imposed by chemotherapeutics as a part of their mechanism of action. The role of metabolic stress in the 
mechanism of action of chemotherapeutics is becoming increasingly well established in the literature. We take a 
look at two such metabolic stresses: ATP depletion and oxidative stress. ATP depletion has long been targeted as 
a possible adjutant strategy for increasing the effectiveness of chemotherapy37,38. For example, one study showed 
that intracellular levels of ATP are critical for drug resistance in colon cancer cell lines39. Another study showed 
that cellular bioenergetic propensity was correlated with decreased sensitivity to sorafenib40. However, in the latter 
study, activation of oxidative phosphorylation, accompanied by an increase in ATP levels, sensitized the cells to 
sorafenib, potentially indicating that ATP is not the critical factor governing sorafenib sensitivity. NADPH is a key 
cofactor that is responsible for combatting damage by reactive oxygen species within the cell by maintaining the 
reduced state of cofactors pools such as glutathione that can neutralize reactive oxygen species. Oxidative stress 
has been shown to sensitive tumor cells to chemotherapeutics41. One study showed that inhibition of G6PDH, 
the committed step of the pentose phosphate pathway that is regulated by the NADPH/NADP ratio, sensitizes 
cisplatin-resistant cancer cells42. Previous work has shown that the PKM2 isozyme implicated in inducing the 
Warburg metabolic phenotype also responds to reactive oxygen species by increasing oxidative stress resistance 
through increasing pentose phosphate pathway flux43. By investigating the top correlated drugs, we also identified 
a number of drugs that had previously been shown to induce apoptosis via an oxidative stress-dependent mecha-
nism (Supplementary Data). Given this evidence, it seems possible that ATP depletion and NADPH depletion can 
both be sensitizers of chemotherapeutics in different contexts; however, the molecular mechanisms underlying 
this relationship appear yet to be elucidated in the majority of cases.
We note that stress resistance has been associated with the appearance of aerobic glycolysis in other contexts 
than malignant transformation. Yeast has been shown to shift toward anaerobic glycolysis during normal growth 
in order to minimize energy demands and stresses associated with aerobic metabolism44. Immune T cells have 
been shown to exhibit aerobic glycolysis45, and T cell activation has been shown to be ROS-dependent46. Aerobic 
glycolysis also appears in stem cells, where maintaining a reductive state appears to be important for the potential 
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to self-renew47,48. Virus infection has also been shown to induce the Warburg effect in infected cells49,50, and this 
shift has been shown to counteract virus-induced reactive oxygen species production50. Additionally, the brain 
has been shown to exhibit various levels of aerobic glycolysis, with possible implications in Alzheimer’s disease51, 
although ties to oxidative stress have not been demonstrated yet to our knowledge.
This work presents a cohesive framework underlying high flux metabolism in cancer cell lines. Several natural 
questions arise regarding the universality of the presented metabolic structure. First, whether these results apply 
to non-cancer rapidly growing cells is unknown; however, it has been shown that the Warburg effect appears 
in many physiological contexts, and thus it appears likely that some of the structure may be consistent between 
cancer and healthy growing cells. The overflow metabolism we identify within the serine and glutamine groups 
has been shown in stem cells52 and as a regulatory mechanism for pyrimidines in E. coli53. Having a sole high 
uptake amino acid may simplify the coordination required to control amino acid uptake at levels required by 
biosynthetic demand.
Second, the relevance of cancer metabolic hallmarks identified in cell culture to in vivo cancer metabolism 
has been called into question. For example, certain cancers do not exhibit the Warburg effect in vivo, and other 
cancer subtypes show an importance of de novo serine synthesis54,55 whereas serine uptake is dominant in the 
cancer cell line data. Thus it appears that there are likely multiple basic metabolic states that cancer can adopt, and 
understanding the differences in this structure is likely a fruitful avenue for further work. Furthermore, the results 
presented are for unperturbed cells growing in culture, and understanding how the basic structure changes under 
metabolic perturbation such as hypoxia will be important as well. Finally, similar analysis of primary tumors and 
tumor progression, and comparative analysis of subtypes (e.g. AML1 though 5) would lead to a finer grained view 
of cancer metabolism of clinical importance. Furthermore, within a tumor or tumor microenvironment it has 
been established that sub-populations of cells exist with different metabolic states56. The relevance of metabolic 
traits of metabolic traits of cancer cells in culture to the metabolic states of heterogeneous cancer cells in a tumor 
requires further investigation. However, we remarkably noticed no separation in metabolic state by cancer tissue 
of origin, suggesting that the metabolic framework we describe is a highly conserved feature of a rapidly growing 
state in culture. The results presented may serve as a baseline for understanding metabolic homeostasis and global 
regulation of metabolism.
Another area requiring further study is the role of lipid metabolism in the cancer metabolic phenotype as 
described in this work. There was very little data on lipid uptake in the exometabolomic study used to constrain 
metabolite uptakes11, thus, for example there is no way to know whether beta oxidation is significantly active in 
these lines. Using standard cellular lipid compositions (Supplementary Data), we estimated sinks of cytosolic 
NADPH and found that fatty acid synthesis and cholesterol synthesis are the dominant known requirements for 
NADPH (Supplementary Fig. 5a). However, there may also be additional unknown requirements for NADPH to 
combat oxidative stress. Elucidating the interplay of oxidative stress, lipid homeostasis, and NADPH would help 
to better understand the apparent excess of cofactor production occurring in these cell lines.
This study attempted to integrate various qualitative and quantitative data sources to identify general prin-
ciples underlying the metabolic phenotype in cancer cell lines. A key issue in such a study is the quality of data 
used. In the course of the investigation, we identified several data sets that we found to be of insufficient quality 
to include for analysis. Other data, such as the exometabolomic data11 and cellular protein content14, required 
additional curation to use with confidence. Even still, it is important to examine any hypothesis from multiple 
angles and using multiple data sets to minimize the chance of data issues to cause false conclusions to be drawn. 
For example, in the case of examining the possible role of macromolecular crowding in the Warburg effect, we 
used two independent data sets on the cell protein content: one on high throughput proteomics13 to estimate the 
quantitative fraction of the proteome affected by the shift between the aerobic and Warburg phenotype, and one 
on total cell protein content14 to determine whether there was a correlation between the apparent intracellular 
crowding as estimated by cell protein density and the degree of Warburg effect manifested in the cell line. In 
this case, neither data set supported protein crowding at the whole cell level as a driving factor underlying the 
Warburg effect.
Another technical area of a data analysis study such as this is determining the desired complexity of the 
relationships investigated. In the case of this study, we largely looked at simple correlations between variables 
in an effort to maximize the interpretability of any findings. However, more complex grouping of variables and 
non-linear relationships could be found with more advanced statistical and machine learning methods. We 
attempted this approach initially, but found that showing the interpretability and statistical significance of com-
plex signatures was a challenging task, especially faced with the difficulty of multiple hypothesis testing in cases 
where hundreds of thousands of data points from various data types are available, as are for the NCI60 cell lines. 
However, it is quite likely that more complex relationships are yet to be discovered in the data and this may prove 
a useful area of investigation.
This work involved the use of a simplified ‘core’ model of metabolism derived from human Recon 2. This 
model consisted of pathways involved in core energy metabolism and production of known biomass precur-
sors. The use such a model is always at risk of ‘missing’ a key pathway that could affect model predictions. In the 
case of this study, our calculations were predominantly based on measured growth and metabolite uptake and 
secretion data. We attempted to include any pathways that had been measured to be active in prior 13C tracing 
studies of which we were aware. Still, there are a number of pathways, such as lipid catabolism as mentioned, 
for which we did not have any ‘functional’ (i.e. flux) data. Thus, the conclusions in this work are subject to be 
modified if pathways carrying a large amount of flux are later characterized, for example lipid metabolic, protein 
glycosylation, and epigenetic methylation and acetylation are relatively under-characterized from a quantitative 
flux perspective.
The results of this study suggest two avenues of inquiry. First, while the NCI60 cell line panel is historically 
important due to its high degree of characterization, it will be important to determine whether the metabolic 
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structure described in this study is conserved in primary tumors. Second, as the overflow metabolites (lactate, 
glutamate/alanine, glycine) coupled to high uptake metabolites (glucose, glutamine, serine) occur at branch 
points upstream of catabolic pathways in the mitochondria, we hypothesize that mitochondrial catabolic capac-
ity may be a limiting constraint preventing complete substrate catabolism in high uptake metabolism in cancer 
cells. Investigation of the role of mitochondrial catabolic capacity in regulating the cancer metabolic phenotype 
may thus be a fruitful approach. The broad range of important metabolic pathways that lie in the mitochondria 
is becoming increasingly appreciated57. Further elucidation of the fate of the excess redox and energy produced 
in cancer cell lines should consolidate our fundamental understanding of the hallmarks of cancer metabolism 
established here, and guide efforts at developing new chemotherapeutic strategies.
Methods
Construction of a core cancer model. To construct a minimal model, we included reactions necessary for 
biomass formation and primary metabolite catabolic pathways, while excluding anabolic pathways not associated 
with core biomass precursor production as well as secondary catabolic pathways. The primary distinction to be 
made was thus determining which reactions belong to primary and secondary catabolic pathways. This classi-
fication was performed algorithmically with manual justification based on (1) literature evidence12,29,30 and (2) 
feasibility based on modeling results.
The following pathways were included: (1) pathways required for synthesis of biomass precursors, (2) core 
energy metabolism (glycolysis, the pentose phosphate pathway, the TCA cycle, the electron transport chain, and 
the malate aspartate shuttle), (3) pathways previously shown to be active in cancer cell lines under normal condi-
tions12,29, (4) cofactor transfer reactions for NTPs and redox groups, (5) pathways involved with essential and/or 
high uptake/secretion metabolites, (6) pathways involved in catabolism of essential and/or high uptake/secretion 
metabolites, (7) pathways involved in cofactor regeneration and small metabolite processing/transport for cofac-
tors/small metabolites produced in pathways gathered from the previous steps. Pathways that were excluded as a 
result of these criteria tend to have the following properties: (1) pathways that have unknown activity but due to 
small flux can be thought of as noise in approximations (e.g. glycosylation, EAA anabolic pathways, beta-alanine), 
(2) pathways removed because not measured to be major contributor to catabolism of high uptake metab-
olites (GLUDC, SERHL and methylglyoxyl), (3) pathways that use high uptake metabolites only as cofactors 
(e.g. cysteine production from serine, where cysteine was not measured).
In general, we found that the addition of further pathways beyond those defined above would have to be 
accompanied by additional assumptions on uptake rates or cellular demands related to these pathways that would 
have made the modeling useless for practical differentiation between metabolic function across cell lines. As an 
example, we look at the possibility of including the methionine pathway. We found that modeling this pathway 
is difficult because the pathway is adjacent to cysteine metabolism, and the uptake of cysteine was not measured. 
Cysteine requires methionine to synthesize unless cysteine is directly taken up. However, not enough methio-
nine is taken up to satisfy the biomass requirement for both amino acids. Thus, when we included this pathway 
along with biomass demands on methionine and cysteine, none of the cell lines were able to meet biosynthetic 
demands. The possibility of including this pathway was originally examined when we were defining the scope 
of the core model, and we discovered that it was not possible to model without making up an artificial cysteine 
uptake, which was problematic.
Other pathways are difficult to include because their composition in biomass is unknown. Specifically, 
the glycosylation pathway might be very interesting to study across the NCI60 cell lines; however, without 
glyco-profiling these NCI60 cell lines, we have no basis for any differential production across the cell lines, analo-
gous to differential DNA production based on karyotype for example, and so any modeling we could do of these 
pathways is extremely limited. Thus, we only are able to include an approximation of the carbohydrate macro-
molecule content of the cell dry weight in the biomass without any meaningful specification of the particular 
macromolecule form of those carbohydrates.
Based on this approach, a core metabolic network of 382 reactions (Supplementary Data) was extract from 
the latest human metabolic network reconstruction22. Gene58 and protein expression analysis13 showed that this 
core set of reactions is highly conserved between cell lines, with the majority of reactions being highly expressed 
in all NCI60 lines (Supplementary Fig. 3b). The core metabolic network was used to account for observed physi-
ological functions, i.e. growth and measured uptakes, and minimize the influence of pathways with an unknown 
functional status on the network’s flux state.
Cell-specific biomass composition determination. Cell biomass is composed of protein, lipids, DNA, 
RNA and small molecules, in weight fractions determined by cell composition studies26. Average protein amino 
acid composition was taken from literature24,59,60. Approximate DNA deoxyribonucleotide composition was set 
based on genomic base frequency taking into account the karyotype of the NCI60 lines23. RNA ribonucleotide 
composition was determined based on measured mass fractions24,59,60. Lipid composition was set based on meas-
ured lipid composition for high concentration lipids. Small molecule weight fractions were determined for several 
high concentration non-essential metabolites using literature concentrations, using a typical cell dry weight of 
0.2 ng/cell and cell volume of 2 pL/cell when unit conversions were necessary. Without any specific information 
on protein fraction of cell dry weight across the NCI60 cell lines, we assumed a constant value of 70% of dry 
weight. For the remainder of the non-protein cell dry weight, we used the measured karyotype of the cell lines 
to estimate the DNA content, e.g. tetraploid cell lines would have twice the mass fraction of DNA as diploid cell 
lines. The remainder of the cell biomass that was not accounted for by protein or DNA was distributed based on 
measured values among lipids and RNA.
We chose to set the macromolecule weight fractions to be constant between lines. Previous studies show 
minimal variance between macromolecule weight fractions for particular types of cells, such as hybridoma cells 
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and Chinese hamster ovary cells24,59,60. Other cell types, such as liver cells, may have significantly different mac-
romolecule weight fractions, but cell lines derived from such tissues are not present in the NCI60 panel. Also, 
although cell composition has also been reported to change across growth conditions61, the NCI60 panel was 
subject to uniform growth conditions in the studies generating the data used in this study. Furthermore, there 
is the question of whether cell composition changes with cell size. One study showed that doubling of cell size 
resulted in approximate doubling of respiration, suggesting the protein content scales proportionally to size62. 
Also, as volume changes, the cell surface area (SA) to volume (V) ratio changes, and thus it is possible that the 
lipid weight fraction of the cell changes as well. However, compartment size has been shown to be approximately 
linearly correlated with total volume32, and ER membrane alone is reported to be over 10 times the fraction of 
the total membrane as the cytoplasmic membrane63, suggesting SA/V differences mean little in terms of lipid 
requirements. Thus, we assumed that the macromolecule composition was invariant across cell lines, although 
cell sizes differ. Protein content and cell volume data for the NCI60 was recently published. However, this data was 
insufficient to set cell-specific biomass macromolecule weight fractions, as the cell dry weight was not measured. 
We examined the impact of varying the protein fraction from 0.7 to 0.6, and found that the correlation between 
calculated flux states was greater than 0.99 for the same cell line (Supplementary Data). However, altering the 
protein fraction further caused the flux balance analysis problem to become infeasible for a subset of the cell lines, 
as the altered protein dry weight content also changes the amino acid requirement for these cell lines, and since 
essential amino acids are limiting in a subset of the lines, this limitation can become constraining, resulting in the 
uptake and growth rate constraints becoming infeasible.
To determine the cell-specific dry weights, we integrated cell volume data with the uptake rates as follows. 
First, the amount of biomass sustainable by each cell was determined by maximizing the growth through each line 
using FBA while constrained by measured uptakes in per cell units. Then, this sustainable biomass was corrected 
using measured protein content data as follows. If the sustainable protein, taking protein as 0.70 of total cell dry 
mass, is less than the measured protein, a value of 95% of the sustainable protein measurement was used as the 
estimate of cellular protein. This was done because the measured protein could not be sustained by the measured 
uptake rates, which we assumed was due to error in the measured protein. Measured protein was assumed to be 
the greater source of error because the measured uptake rates are highly correlated and there was no general bias 
of sustainable protein being greater or less than measured protein. Also the measured protein showed a relatively 
low agreement with cell volumes (Pearson R2 = 0.23) and we observed certain spurious data points causing con-
cern. For example, the SR line was reported to have a protein content of 0.021 ng/cell, which given the reported 
cell volume and average protein density would result in a dry weight fraction of protein of approximately 0.08, 
which is substantially lower than measured values around 0.7. Volume measurements were based in microscopy, 
and thus were seen as less error prone than protein content measurements which require cell count estimation, 
which can be a significant source of error. When sustainable protein was greater than measured protein, the 
measured value was used to correct the sustainable protein, using the formula mestimate = mmeasured + 0.25*(msustain-
able − mmeasured). This formula was chosen based on resulting agreement with cell volume data. The correlation of 
estimated protein content with cell volume (Pearson R2 = 0.60) was higher than either measured protein (Pearson 
R2 = 0.23) or sustainable protein (Pearson R2 = 0.52).
Curation of exometabolic data. Published metabolite uptake and release (exometabolomic) data on the 
NCI60 lines was re-processed in a semi-automated process. The original dataset was processed by correcting for 
drift in the peak area standardization across runs by a linear L1 regression of blank media standards. However, 
upon detailed inspection of the drift for different metabolites, it was apparent that the drift was highly non-linear 
for some metabolites. The effect of applying a linear approximation in these non-linear cases was that metabolite 
uptakes were significantly mis-represented, and in some cases, metabolites were actually not exchanged sub-
stantially at all, once a non-linear drift correction was applied. We manually created non-linear approximations 
of drift for each metabolite in Mathematica based on the media standards for each metabolite. We applied these 
non-linear corrections to the raw data to recalculate the metabolite uptake and release profiles.
Calculation of metabolic flux states. To calculate metabolic flux states, a stoichiometric model of central 
and growth metabolism was extracted from the latest global human metabolic network reconstruction, Recon 264. 
Then, for each cell line, this model was constrained by cell line-specific data, including growth data15, metabolic 
uptake and secretion profiles11, and an estimate of cell mass based on sustainable biomass that was validated 
against measured cell sizes14. ATP costs due to cellular maintenance functions was set to be 1.07 mmol/gDW/hr 
based on measurements25. Twenty-three metabolites had uptakes constrained by measured data, consisting of 
glucose, lactate, and amino acids, which accounted for greater than 99% of observed metabolic exchange fluxes in 
the NCI60 cell line data set65 (Supplementary Fig. 3c). The amino acids histidine and cysteine were not analyzed 
due to lack of uptake measurement, while methionine was excluded due to its close relationship with cysteine. 
Because methionine can be used for cysteine biosynthesis, the lack of cysteine measurement caused us to be 
unsure of the amount of methionine used to protein synthesis directly versus cysteine biosynthesis. Furthermore, 
two flux splits, that between glycolysis and the pentose phosphate pathway (PPP), and between pyruvate dehydro-
genase and pyruvate carboxylase, were constrained to be 90/10 each, based on an approximate average of previous 
13C tracing studies performed on the NCI60 lines (Supplementary Data). The A549 cell line had a reported value 
of 16% of glucose uptake going to the PPP, while the MCF7 cell line had a reported value of 5% of glucose uptake 
going to the PPP. Furthermore, the isocitrate and glutamate dehydrogenases were assumed to equally utilize NAD 
versus NADP as substrates.
Metabolic flux states were then calculated by solving the flux balance analysis problem:
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where S is the stoichiometric matrix, v is the reaction flux vector, α and β are vectors for the lower and upper 
bounds of the reactions, and cv,i corresponds to the imposed reaction objective for each ith sink reaction. A num-
ber of objectives were evaluated, including maximization and minimization of ATP production, maximization 
and minimization of cellular redox production, and minimization of overall cellular flux, a proxy for minimizing 
the proteomic cost of enzyme synthesis (Supplementary Data). We found that maximization of mitochondrial 
NAD(P)H gave the best agreement with 13C tracing data12,13, verifying the solutions on a subset of the NCI60 
lines. This reaction is defined as NADPH − > NADP + H, for compartment-specific metabolites, and represents 
the irreversible loss of a redox ‘charge’ on the NADP moiety, forcing its replenishment by metabolic pathways 
to satisfy mass balance. Other redox production reactions that we evaluated, e.g. for NADH, were defined in an 
analogous manner with metabolites specific to the compartment.
To summarize the flux calculation procedure, we:
(1) Started with a core metabolic model of a cancer cell, as defined elsewhere in the manuscript.
(2) Constrained uptake fluxes based on cell line-specific measurements and certain non-cell line-specific approx-
imations, specifically ATP maintenance, oxygen uptake, and certain flux splits.
(3) Created a partially cell line-specific biomass function for each cell line based on the measured karyotype of 
each cell line.
(4) Constrained growth rate based on cell line-specific measurements.
(5) Solved a flux balance analysis optimization problem with an NADPH production objective.
The specific constraints used are provided in the “FBA constraints” table in the Supplementary Data.
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